Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Xavier University of Louisiana.
- Study ID
- NCT03869216
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 40 Years - 69 Years
- Healthy Volunteers
- Accepted
Interventions
- Educational Shared Decision-Making Intervention — BEHAVIORALThe intervention includes a web-based patients' decision aid about PSA-based prostate cancer screening, risks and preferences. The providers receive a summary of the USPSTF 2018 guidelines and main components of the Agency for Healthcare Research and Quality (AHRQ) SHARE curriculum, a link to a video of a prototypical shared decision making conversation, and a laminated shared decision making reminder card.
Study Details
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.
Key Dates
- Start date
- Aug 17, 2020
- Status verified
- Dec 2025
- Primary completion
- Nov 30, 2023
- Completion
- Dec 31, 2023
Study Design
- Enrollment
- 161 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: InterventionPatients in the intervention will receive the educational intervention
- No Intervention: Usual CarePatients in the control arm will receive usual care
Primary Outcome Measure
Shared Decision-making [ Time Frame: One month after audio-recorded visit ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Tulane Medical Center | New Orleans | Louisiana | 70112 | - |
Find similar trials in New Orleans, LA
By condition
By specialty
By research site
Related Studies
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPHASE1 · Recruiting · Amgen · Duarte, California
- Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerPHASE4 · Recruiting · Novartis Pharmaceuticals · Scottsdale, Arizona
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)Recruiting · Axonics, Inc. · Birmingham, Alabama